Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

24432 ARTÍCULOS , VIENDO DEL 4531 AL 4545

A Synopsis of Multitarget Potential Therapeutic Effects of Huperzine A in Diverse Pathologies-Emphasis on Alzheimer's Disease Pathogenesis

Shukla M, Wongchitrat P, Govitrapong P.

Neurochem Res. 2022 May;47(5):1166-1182. doi: 10.1007/s11064-022-03530-2. Epub 2022 Feb 5.

Importance of the locus coeruleus-norepinephrine system in sleep-wake regulation: Implications for aging and Alzheimer's disease

Van Egroo M, Koshmanova E, Vandewalle G, Jacobs HIL.

Sleep Med Rev. 2022 Apr;62:101592. doi: 10.1016/j.smrv.2022.101592. Epub 2022 Jan 21.

What have we learnt from past failures in Alzheimer's disease drug discovery?

Cacabelos R.

Expert Opin Drug Discov. 2022 Apr;17(4):309-323. doi: 10.1080/17460441.2022.2033724. Epub 2022 Feb 6.

Public opinion regarding U.S. Food and Drug Administration approval of aducanumab and potential policy responses: A nationally representative survey

DiStefano MJ, Alexander GC, Polsky D, Anderson GF.

J Am Geriatr Soc. 2022 Jun;70(6):1685-1694. doi: 10.1111/jgs.17692. Epub 2022 Feb 7.

Metformin in Alzheimer's disease: An overview of potential mechanisms, preclinical and clinical findings

Khezri MR, Yousefi K, Mahboubi N, Hodaei D, Ghasemnejad-Berenji M.

Biochem Pharmacol. 2022 Mar;197:114945. doi: 10.1016/j.bcp.2022.114945. Epub 2022 Feb 5.

The effects of involvement in training and volunteering with families of people with dementia on the knowledge and attitudes of volunteers towards dementia

Cheung DSK, Ho LYW, Kwok RKH, Lai DLL, Lai CKY.

BMC Public Health. 2022 Feb 8;22(1):258. doi: 10.1186/s12889-022-12687-y.

Therapeutic potential of phosphodiesterase inhibitors for cognitive amelioration in Alzheimer's disease

Xi M, Sun T, Chai S, Xie M, Chen S, Deng L, Du K, Shen R, Sun H.

Eur J Med Chem. 2022 Mar 15;232:114170. doi: 10.1016/j.ejmech.2022.114170. Epub 2022 Feb 3.

Interaction Between Diet and Microbiota in the Pathophysiology of Alzheimer's Disease: Focus on Polyphenols and Dietary Fibers

Ticinesi A, Mancabelli L, Carnevali L, Nouvenne A, Meschi T, Del Rio D, Ventura M, Sgoifo A, Angelino D.

J Alzheimers Dis. 2022;86(3):961-982. doi: 10.3233/JAD-215493.

Microglia in Alzheimer's Disease: An Unprecedented Opportunity as Prospective Drug Target

Kulkarni B, Cruz-Martins N, Kumar D.

Mol Neurobiol. 2022 May;59(5):2678-2693. doi: 10.1007/s12035-021-02661-x. Epub 2022 Feb 12.

Recent Advancements in Strategies for Abnormal Protein Clearance in Alzheimer's Disease

Gong B, Ji W, Chen X, Li P, Cheng W, Zhao Y, He B, Zhuang J, Gao J, Yin Y.

Mini Rev Med Chem. 2022;22(17):2260-2270. doi: 10.2174/1389557522666220214092824.

Cathepsin B-A Neuronal Death Mediator in Alzheimer's Disease Leading to Neurodegeneration

Sharma A, Swetha R, Bajad NG, Ganeshpurkar A, Singh R, Kumar A, Singh SK.

Mini Rev Med Chem. 2022;22(15):2012-2023. doi: 10.2174/1389557522666220214095859.

Can We Use Ginkgo biloba Extract to Treat Alzheimer's Disease? Lessons from Preclinical and Clinical Studies

Xie L, Zhu Q, Lu J.

Cells. 2022 Jan 29;11(3):479. doi: 10.3390/cells11030479.

Physical Activity Improves Cognition and Activities of Daily Living in Adults with Alzheimer's Disease: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

Zhou S, Chen S, Liu X, Zhang Y, Zhao M, Li W.

Int J Environ Res Public Health. 2022 Jan 22;19(3):1216. doi: 10.3390/ijerph19031216.

p27, The Cell Cycle and Alzheimer´s Disease

García-Osta A, Dong J, Moreno-Aliaga MJ, Ramirez MJ.

Int J Mol Sci. 2022 Jan 21;23(3):1211. doi: 10.3390/ijms23031211.

Selected Natural Products in Neuroprotective Strategies for Alzheimer's Disease-A Non-Systematic Review

Wojtunik-Kulesza K, Oniszczuk T, Mołdoch J, Kowalska I, Szponar J, Oniszczuk A.

Int J Mol Sci. 2022 Jan 21;23(3):1212. doi: 10.3390/ijms23031212.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias